39 | CannabinoidsIBA
10/2022
-
09/2001 |
24 | EndocannabinoidsIBA
01/2021
-
03/2003 |
15 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2021
-
07/2005 |
12 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022
-
12/2002 |
12 | AM 1241IBA
01/2022
-
09/2001 |
11 | Pharmaceutical PreparationsIBA
01/2022
-
11/2003 |
11 | CB2 Cannabinoid ReceptorIBA
01/2022
-
02/2003 |
10 | RimonabantIBA
03/2019
-
02/2004 |
9 | 3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA
01/2022
-
06/2011 |
9 | Paclitaxel (Taxol)FDA LinkGeneric
01/2022
-
11/2008 |
9 | AM4113IBA
02/2021
-
12/2007 |
8 | N-acylethanolaminesIBA
01/2022
-
02/2015 |
8 | anandamide (arachidonylethanolamide)IBA
01/2019
-
08/2002 |
7 | Analgesics (Analgesic Drugs)IBA
10/2018
-
02/2003 |
6 | Morphine (MS Contin)FDA LinkGeneric
10/2022
-
02/2013 |
6 | Opioid Analgesics (Opioids)IBA
10/2022
-
02/2013 |
6 | AcidsIBA
01/2022
-
02/2015 |
6 | amidaseIBA
01/2022
-
02/2015 |
6 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
01/2021
-
08/2002 |
6 | NicotineFDA Link
01/2020
-
04/2012 |
5 | EnzymesIBA
01/2021
-
03/2012 |
5 | Proteins (Proteins, Gene)FDA Link
12/2020
-
08/2002 |
5 | LigandsIBA
04/2016
-
03/2008 |
4 | palmidrolIBA
01/2021
-
02/2015 |
4 | LipidsIBA
01/2021
-
08/2010 |
4 | Dronabinol (THC)FDA LinkGeneric
01/2019
-
12/2012 |
4 | Cannabinoid Receptor AgonistsIBA
03/2012
-
02/2003 |
3 | Monoacylglycerol LipasesIBA
01/2022
-
03/2012 |
3 | methanandamideIBA
10/2021
-
02/2013 |
3 | AM6545IBA
02/2021
-
10/2017 |
3 | Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021
-
02/2015 |
3 | CytokinesIBA
12/2020
-
03/2012 |
3 | Glycerol (Glycerine)FDA LinkGeneric
01/2019
-
10/2012 |
3 | N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA
01/2016
-
03/2003 |
3 | 3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA
08/2015
-
03/2012 |
3 | AM 251 (AM251)IBA
04/2014
-
12/2007 |
3 | Glycoproteins (Glycoprotein)IBA
01/2014
-
11/2008 |
3 | 9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA
08/2013
-
01/2013 |
2 | MonoglyceridesIBA
09/2021
-
01/2016 |
2 | Fatty Acids (Saturated Fatty Acids)IBA
09/2021
-
01/2013 |
2 | AlbuminsIBA
02/2021
-
10/2017 |
2 | Interleukin-10 (Interleukin 10)IBA
12/2020
-
03/2012 |
2 | Serotonin (5 Hydroxytryptamine)IBA
11/2019
-
10/2018 |
2 | AM9405IBA
11/2019
-
10/2018 |
2 | N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA
01/2019
-
01/2019 |
2 | Dopamine (Intropin)FDA LinkGeneric
01/2019
-
02/2013 |
2 | Therapeutic UsesIBA
12/2018
-
10/2011 |
2 | Ethanol (Ethyl Alcohol)IBA
01/2018
-
11/2008 |
2 | Methamphetamine (Desoxyn)FDA LinkGeneric
12/2014
-
02/2013 |
2 | iodopravadoline (AM 630)IBA
04/2014
-
11/2009 |
2 | Sulfonic AcidsIBA
01/2014
-
11/2009 |
2 | pyrazoleIBA
02/2013
-
02/2004 |
2 | Mesylates (Mesylate)IBA
02/2013
-
01/2013 |
2 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2013
-
08/2006 |
2 | Messenger RNA (mRNA)IBA
03/2012
-
11/2009 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2011
-
11/2008 |
2 | BenzopyransIBA
11/2008
-
10/2006 |
2 | Capsaicin (Zostrix)FDA Link
02/2004
-
10/2003 |